790 Memorial Drive, Suite 204
2 articles with Korro Bio
Korro Bio, Inc. , a biotechnology company developing single-base RNA editing therapies, today announced that Ram Aiyar, Ph.D., MBA, chief executive officer, will present an update on Korro’s progress at the 39 th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Thursday, January 14, 2021 at 8:05 a.m. E.T. using a virtual platform. About Korro Bio, Inc. Korro is leading the
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.